我要投票 哈兽研在兽药行业中的票数:168
· 外 推 电 报 ·
2025-02-24 03:50:11 星期一

【哈兽研是哪个国家的品牌?】

哈兽研是什么牌子?「哈兽研」是 哈尔滨维科生物技术有限公司 旗下著名品牌。该品牌发源于黑龙江哈尔滨市,由创始人付董在1992年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力哈兽研品牌出海!通过在本页面挂载哈兽研品牌的产品链接和联系邮箱,可以提高哈兽研产品曝光!跨境电商爆单神器,目前只要100元/年哦~

成立于1992年,国内知名的全系列禽流感疫苗制造品牌,专业从事动物疫病防治用生物制品的研发、生产、销售、技术咨询与服务的兽用生物制品企业


哈尔滨维科生物技术有限公司(简称维科生物)是中国农业科学院哈尔滨兽医研究所(简称哈兽研)独资的一人有限责任公司,是农业部禽流感疫苗生产企业和技术依托单位。

维科生物成立于1992年,专门从事动物疫病防治用生物制品的研发、生产、销售、技术咨询与服务,是具有独立法人资格的企业,主要是对哈兽研科技成果进行孵化、转化及孵化后的推广。

维科生物现有员工中具有大专以上学历人员超过70%,其中高级职称人员4人,副高级职称人员21人,具有博士、硕士以上学位人员62人。中高级职称人员中,绝大多数是哈兽研所获科技成果的完成人。

公司新址落成于2008年,并于2009年7月整体通过农业部兽用生物制品GMP验收。新址园区面积约11.4万平方米,建筑面积6.2万平方米,共有17条生产线,主要设备为进口,自动化程度高,工艺优良。另有国家禽流感疫苗抗原储备库、质量检验、研发、动物实验、立体仓储等配套设施。

依托维科生物的黑龙江兽用生物制品工程技术研究中心与哈尔滨市兽用生物制品工程研究中心运行良好。经国家发改委立项与批准,维科生物参股组建的动物用生物制品国家工程研究中心也已正式运行。

维科生物生产的历代禽流感疫苗均在禽流感疫情防控中得到了广泛应用,解决了不同禽种的有效免疫问题,为我国禽流感疫情的防控做出重要贡献。目前维科生物的禽流感疫苗已在越南、埃及、印尼广泛应用。

我公司秉承“团结、奉献、求实、创新”的哈兽研精神,本着“责任重于泰山,细节决定成败”的企业文化理念,以维护动物健康和保障动物性食品安全为宗旨,以追踪兽用生物制品技术前沿为目标,高起点地为畜牧业发展服务,并努力将企业发展成为出色的兽用生物制品企业。


英文翻译:Founded in 1992, Harbin Weike Biotechnology Co., Ltd. (hereinafter referred to as "Weike biotechnology") is a famous brand of avian influenza vaccine manufacturing in China, specializing in the R & D, production, sales, technical consultation and service of biological products for animal disease prevention and control. It is a wholly-owned one person limited liability company of Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences (hereinafter referred to as "Harbin Veterinary Research") The company is an avian influenza vaccine manufacturer and technical support unit of the Ministry of agriculture. Founded in 1992, Vico biology specializes in the R & D, production, sales, technical consultation and service of biological products for animal disease prevention and control. It is an enterprise with independent legal personality, which mainly incubates, transforms and promotes the scientific and technological achievements of Harbin animal research. At present, more than 70% of the employees have college degree or above, including 4 with senior professional title, 21 with deputy senior professional title, 62 with doctor's degree or above. Most of the middle and senior professional titles are the Achievers of scientific and technological achievements of Harbin animal research institute. The company's new site was completed in 2008 and passed the GMP acceptance of animal biological products by the Ministry of agriculture in July 2009. The new site covers an area of about 114000 square meters, with a building area of 62000 square meters. There are 17 production lines. The main equipment is imported, with high degree of automation and excellent technology. There are also national avian influenza vaccine antigen storage, quality inspection, research and development, animal experiments, three-dimensional storage and other supporting facilities. Heilongjiang animal biological products engineering technology research center and Harbin animal biological products Engineering Research Center Based on Vico biology are in good operation. With the approval of the national development and Reform Commission, the National Engineering Research Center for animal biological products, which was established with the participation of Vico biology, has also been officially put into operation. All the avian influenza vaccines produced by Vico biology have been widely used in the prevention and control of avian influenza epidemic, which solved the effective immune problems of different avian species and made important contributions to the prevention and control of avian influenza epidemic in China. At present, the avian influenza vaccine of vyco has been widely used in Vietnam, Egypt and Indonesia. Our company adheres to the spirit of "unity, dedication, truth-seeking and innovation", the corporate culture concept of "responsibility is more important than Mount Tai, details determine success or failure", the purpose of maintaining animal health and ensuring animal food safety, the goal of tracking the forefront of animal biological products technology, the high starting point for animal husbandry development services, and strive to develop the enterprise into an excellent animal use Biological products enterprises.

本文链接: https://www.waitui.com/brand/19aeb19ab.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

一汽大众ID.系列部分车型官降至高5.5万元

一汽-大众宣布对旗下ID.系列部分车型进行降价,最高降幅达5.5万元。此次降价活动涉及ID.4 CROZZ和ID.6 CROZZ两款车型,无门槛一口价分别为13.99万元和19.59万元起,还可叠加官方置换补贴至高1万元、国家置换补贴至高2万元。(财联社)

2小时前

2025年中央一号文件发布

36氪获悉,2025年中央一号文件2月23日发布,《中共中央 国务院关于进一步深化农村改革 扎实推进乡村全面振兴的意见》提出,以改革开放和科技创新为动力,巩固和完善农村基本经营制度,深入学习运用“千万工程”经验,确保国家粮食安全,确保不发生规模性返贫致贫,提升乡村产业发展水平、乡村建设水平、乡村治理水平,千方百计推动农业增效益、农村增活力、农民增收入,为推进中国式现代化提供基础支撑,这是党的十八大以来第13个指导“三农”工作的中央一号文件。

2小时前

海天味业:公司发行H股备案申请材料获中国证监会接收

36氪获悉,海天味业公告称,公司已于2025年1月13日向香港联交所递交了发行H股股票并在香港联交所主板挂牌上市的申请。公司已向中国证监会报送了关于公司本次发行的备案申请材料并于近日获中国证监会接收。该事项仍存在不确定性,公司将根据进展情况及时履行信息披露义务。

2小时前

山河药辅:股东复星医药拟减持不超过3%公司股份

36氪获悉,山河药辅发布公告,股东上海复星医药产业发展有限公司因经营需要,计划以集中竞价和大宗交易方式合计减持公司股份不超过697.8万股,即不超过公司总股本的3%。

2小时前

镁伽科技正式推出LABILLION™实验室智慧管理平台,并于线上发布

36氪获悉,近日镁伽科技正式推出LABILLION™实验室智慧管理平台,并于线上发布。作为镁伽在“AI for Science(AI4S)”领域的新成果,LABILLION™以AI与自动化技术为核心,针对生命科学研发中长期存在的数据孤岛、系统僵化、流程低效等痛点,为科学家提供从实验设计到数据分析的全链路智能支持,助力科研创新效率的提升。

2小时前

本页详细列出关于维尔康的品牌信息,含品牌所属公司介绍,维尔康所处行业的品牌地位及优势。
咨询